Cargando…
Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194022/ https://www.ncbi.nlm.nih.gov/pubmed/34116680 http://dx.doi.org/10.1186/s12943-021-01385-9 |
| _version_ | 1783706338216378368 |
|---|---|
| author | Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli |
| author_facet | Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli |
| author_sort | Dong, Huaying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8194022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81940222021-06-15 Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli Mol Cancer Correction BioMed Central 2021-06-11 /pmc/articles/PMC8194022/ /pubmed/34116680 http://dx.doi.org/10.1186/s12943-021-01385-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title | Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_full | Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_fullStr | Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_full_unstemmed | Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_short | Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_sort | correction to: activation of lncrna tincr by h3k27 acetylation promotes trastuzumab resistance and epithelial-mesenchymal transition by targeting microrna-125b in breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194022/ https://www.ncbi.nlm.nih.gov/pubmed/34116680 http://dx.doi.org/10.1186/s12943-021-01385-9 |
| work_keys_str_mv | AT donghuaying correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT hujianguo correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT zoukejian correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT yemulin correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT chenyuanwen correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT wuchengyi correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT chenxin correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT hanmingli correctiontoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer |